Search for Clinical Trial Results

Sponsored By

Congenital Myasthenic Syndrome - 11 Studies Found

Status Study
Completed Study Name: Efficacy of Albuterol in the Treatment of Congenital Myasthenic Syndromes
Condition: Congenital Myasthenic Syndrome
Date: 2010-09-15
Interventions: Drug: Albuterol 4 mg twice daily by mouth for adults. The dose for children 6 to 12 years is 2 mg two or
Recruiting Study Name: 3,4-Diaminopyridine Use in Lambert-Eaton Myasthenic Syndrome(LEMS) and Congenital Myasthenic Syndromes (CMS)
Condition:
  • Lambert-Eaton Myasthenic Syndrome
  • Congenital Myasthenic Syndrome Date: 2009-03-30
    Interventions:
    • Drug: 3,4-DIAMINOPYRIDINE Trea
Available Study Name: Treatment Use of 3,4 Diaminopyridine in Congenital Myasthenia and Lambert-Eaton Syndrome
Condition:
  • Congenital Myasthenic Syndrome
  • Lambert-Eaton Myasthenic Syndrom
    Date: 2017-02-21
    Interventions: Drug: 3,4-Diaminopyridine The investigator will prescribe an initial dose of 3,4 diaminopyridine (DAP) b
Available Study Name: Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients
Condition:
  • Lambert-Eaton Myasthenic Syndrome
  • Congenital Myasthenic Syndrome Date: 2014-07-05
    Interventions: Drug: Amifampridine Phosphate Dosage form: tablets contain
Completed Study Name: Pregnancy Outcomes in Congenital Myasthenie Syndrome
Condition: Congenital Myasthenic Syndrome
Date: 2011-11-16
Available Study Name: 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Condition:
  • Lambert-Eaton Myasthenic Syndrome (LEMS)
  • Congenital Myasthenia
    Date: 2013-12-11
    Interventions: Drug: 3,4-diaminopyridine 10mg tablets for up to 100mg per day
Recruiting Study Name: Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes
Condition: Myasthenic Syndromes, Congenital
Date: 2015-09-24
Interventions:
  • Drug: amifampridine phosphate

Recruiting Study Name: Ephedrine for the Treatment of Congenital Myasthenia
Condition: Myasthenic Syndromes, Congenital
Date: 2007-10-07
Interventions: Drug: Ephedrine
No longer available Study Name: Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition: Lambert Eaton Myasthenic Syndrome (LEMS)
Date: 2011-06-20
Interventions: Drug: 3,4-diaminopyridine Treatment will begin with 5mg three times a day or less.
Available Study Name: Treatment Use of 3,4-Diaminopyridine
Condition:
  • Lambert Eaton Myasthenic Syndrome (LEMS)
  • Myasthenic Syndromes, Congenital

Date: 2013-01-06
Interventions:
  • Drug: 3,4-diaminopyridine Trea
Next >>>